Mast cell activation syndrome: Causes, symptoms, and treatments – Medical News Today

Mast cells play an important role in immunity, as they release substances that can trigger the immune system. Mast cell activation syndrome (MCAS) is a condition that causes mast cells to release these substances too frequently and often, resulting in severe allergic reactions.
After detecting an allergen, mast cells are responsible for releasing substances called mediators. This results in inflammation, which is the same response that occurs during an allergic reaction, and helps the body heal.
In people with MCAS, however, mast cells are overactive and cause severe allergic reactions.
This article will discuss MCAS’s causes, risk factors, symptoms, and diagnosis. It will also explore how MCAS differs from mastocytosis, some treatments and remedies, and tips for managing MCAS at home.
Mast cells are immune cells present in the junctions between mucosal and epithelial tissues and the external environment, such as in the gut, lungs, and skin and around blood vessels.
Aside from maintaining various bodily functions, their primary role is to trigger inflammatory responses to defend the body against pathogens and allergens.
When foreign bodies are present, mast cells respond by releasing stored substances, called mediators, from their granules in a process known as degranulation.
These mediators, which include chemicals such as histamine, cause an inflammatory cascade. This results in the recruitment of white blood cells, swelling, smooth muscle constriction, and increased mucus production to destroy the allergen.
In people with MCAS, the immune system inappropriately activates mast cells, causing them to release too many mediators. This results in a person experiencing severe allergic reactions that affect several body systems repeatedly.
There are currently no data on the prevalence of MCAS. This is probably due to its wide range of clinical presentations, which makes it difficult for doctors to identify and confirm its diagnosis.
One 2016 study suggests that MCAS develops due to mutations in the transmembrane tyrosine kinase (KIT) gene, which is a regulator of mast cells. Similarly, an older 2010 study notes that multiple mutations or complex alterations of the mRNA sequence responsible for coding the KIT gene occur in those with systemic MCAS.
A 2013 study suggests the possibility of familial occurrence, but more studies are necessary to determine if MCAS is hereditary.
Although many people cannot identify a trigger for the onset of their MCAS symptoms, most people report exposure to some stimuli. Some potential triggers include:
A person’s symptoms may develop abruptly and irregularly, or they may occur frequently and persistently.
In MCAS, triggers induce a spontaneous release of mediators that can affect multiple systems. Some symptoms that people might experience in different parts of the body include:
A person may receive a diagnosis of MCAS when they present with both clinical symptoms and a laboratory profile indicative of the condition and when a doctor excludes other conditions.
Based on a consensus from the American Academy of Allergy, Asthma & Immunology, a person should meet the following criteria to receive a diagnosis of MCAS:
Although both conditions are diseases of mast cells and present with similar symptoms, they are different.
Mastocytosis occurs when a gene mutation causes the body to produce too many mast cells. MCAS is an activation disorder, which means that a person has an average amount of mast cells but frequently releases an excessive amount of mediators, causing a severe reaction.
If the person meets the criteria for a diagnosis of MCAS, it is important for a doctor to rule out a primary clonal mast cell disorder as the cause.
This requires further blood testing for a mutation called KIT D816V and, depending on those results, may require a bone marrow biopsy. If the bone marrow biopsy is negative, the diagnosis will be “idiopathic” MCAS.
Currently, there is no cure for MCAS. However, its management is similar to anaphylaxis management. Doctors can also provide symptomatic treatment based on an individual’s presentations.
Treatment will typically start with a quick administration of epinephrine, provision of oxygen, and IV antihistamines. Doctors may also provide a person with auto-injectable epinephrine in case of emergencies. People with chronic MCAS may need corticosteroids.
Depending on the person’s symptoms, a doctor may give them one or a combination of the following medications for allergic reactions:
Because stress is also a trigger for mast cell activation in MCAS, a person may also wish to consult with a therapist or learn relaxation techniques and exercises to help manage their stress.
Aside from taking medications, people with MCAS should try to avoid exposure to any trigger that may activate their symptoms.
Some tips and home remedies to help manage MCAS include:
MCAS occurs when mast cells frequently release an excessive amount of mediators in response to triggers. This causes people to experience severe reactions.
There have been few studies on MCAS due to limited awareness and diagnosis of the condition.
People with MCAS have varying symptom presentations and frequencies. Although there is currently no cure for the condition, there are several treatment options that can help manage its symptoms.
Last medically reviewed on September 6, 2021





OUR BRANDS

source